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ABSTRACT
Objective: This study aimed to analyze the physical stability and drug content of zoledronate (ZOL) gel emulsion in virgin coconut oil (VCO) as a new 
pharmaceutical product at 25°C as room temperature and 40°C as an accelerated temperature for a stability physics test.
Methods: The ZOL gel emulsion comprises the following ingredients: 0.16% ZOL powder, 2% carboxymethyl cellulose, 5% VCO, 0.44% sodium 
benzoate, and 0.009% antioxidant butylated hydroxytoluene, and distilled water. Samples of this gel emulsion were stored for 1 month at 25°C and 
40°C, and the parameters used for stability tests were pH, viscosity, spreadability, and adhesive strength. The drug content was also evaluated with a 
spectrophotometer. The ZOL gel emulsion was evaluated against these metrics on days 1, 7, 14, and 28.
Results: The results showed that ZOL pH, viscosity, spreadability, adhesive strength, and drug content gel emulsion were clinically stable over 28 days 
of storage at 25°C, whereas it was not stable when stored at 40°C for the same duration. pH value of ZOL gel emulsion significantly decreased at 28 days 
(p<0.05). Also for viscosity, adhesive strength, and drug content of ZOL gel emulsion  showed statistically significant (p<0.05), except for spreadability 
value (p>0.05). The spreadability value between ZOL gel emulsion that stored at 25°C and at 40°C showed no significant result at 7 and 14 days (p>0.05).
Conclusion: ZOL gel emulsion was stable at 25°C when stored for 28 days, suggesting that this is a suitable storage temperature at which its physical 
stability and drug content can be maintained.
Keywords: Zoledronate, Drug stability, Virgin coconut oil, Orthodontic tooth movement.
INTRODUCTION
Loss of anchorage and a consequent relapse during and after 
orthodontic treatment is one of the leading causes of a poor outcome 
of orthodontic treatment. Nonetheless, this problem remains a 
challenge for orthodontists, who are expected to create a system that 
can achieve desired tooth movement and which can also prevent their 
migration back to their original positions [1]. Anchorage methods 
that are commonly used include headgear, transpalatal bar, nance 
holding appliance, and lingual holding arch; all these are dependent on 
patient compliance [1-3], which, if insufficient, can increase treatment 
time and even result in effects such as caries and gingivitis [1,4]. 
Temporary anchorage devices, such as mini implants, are currently 
popular because they are small, easy to place and remove, and provide 
substantial anchorage. Although mini implants have been effective in 
providing maximum anchorage, several studies have shown that they 
are not always stable after orthodontic force delivery. Inflammation 
around the mini screw area and uncomfortable pain after the required 
procedure has also been noted [1,5,6].
The application of bisphosphonate (BP) has a potential to reduce 
anchorage loss and relapse, in addition to other medications, such as 
nonsteroidal anti-inflammatory drugs and osteoprotegerin protein. 
BP has been used to treat various bone diseases associated with bone 
resorption such as osteoporosis, Paget’s disease, multiple myeloma, 
and metastatic bone cancer because it can selectively inhibit osteoclast 
activities [7,8]. However, the side chain structure of the carbon atom of 
BP (phosphorus-carbon-phosphorus) is the key to its potency because 
it has a high affinity toward hydroxyapatite [9,10]. Recent studies show 
that BPs containing nitrogen (BP-N) are more potent than those without 
nitrogen [1]. Zoledronate (ZOL) is the newest class of BP-N that has a 
heterocyclic ring and is considered 10.000 times more potent than BP 
non-nitrogen; in addition, it has the highest bone affinity [1,9,10].
Recent studies of BP injections in orthodontics have shown that it has 
a significant capability to inhibit osteoclast activity and reduce bone 
resorption [1,10-12]. However, BP injections are invasive and more 
painful than topical applications [10,13]. Studies of the topical form of 
ZOL gel emulsion with virgin coconut oil (VCO) by Parlina et al. have 
shown that osteoclast apoptosis significantly increases after 24 h of 
use in the experimental group that applied of ZOL gel emulsion and 
VCO [13]. The study showed that ZOL gel emulsion with VCO has a 
potency to be an alternative for pharmacology option for orthodontic 
anchorage and stability orthodontic treatment. The use of VCO as the 
oil component in a gel emulsion has many advantages instead of using 
the gel alone. Gel emulsion containing a drug has a long time to attach to 
the skin or mucosa, is easy to apply, has good spreadability, and is more 
comfortable for use by patients [13,14].
Stability testing of pharmaceutical products is a complex procedure 
performed to evaluate the quality, safety, and effectiveness of drug 
formulations, and such tests add time as well as the considerable cost 
to the development and approval of a new drug [15]. The stability of 
ZOL gel emulsion as a new pharmaceutical product was never study 
before, so the aim of this study is to analyze and evaluate the physical 
stability and drug content of ZOL gel emulsion, containing VCO and 
preservative agent (sodium benzoate and the antioxidant butylated 
hydroxytoluene [BHT]) after it has been stored at room temperature 
(25°C) and distribution temperature (40°C). The parameters used 
for the evaluation of the ZOL gel emulsion were pH value, viscosity, 
spreadability, adhesive strength, and drug content.
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MATERIALS AND METHODS
Materials
ZOL powder was procured from Sigma-Aldrich industries (Singapore) in 
April 2018. VCO was purchased from Indogen Ltd. (Jakarta, Indonesia). 
Carboxymethyl cellulose (CMC), sodium benzoate, and the antioxidant 
BHT were procured from Harum Kimia CV (Jakarta, Indonesia) also 
in April 2018. The experiment was conducted at the Research Center 
for Biomedical Engineering (RCBE) and Laboratory of Pharmaceutical 
Formulation and Development Universitas Indonesia, Depok, West Java.
Preparation of ZOL gel emulsion
The ZOL gel emulsion was prepared by mixing all the ingredients into the 
oil base. 0.16% ZOL powder was dissolved in 0.17% phosphate buffer 
saline, and mixed with 5% VCO, 2% CMC, 2.05% Tween, and 89.3% 
distilled water in a beaker glass until the solution was homogenous. 
The 0.44% sodium benzoate and 0.009% BHT were then added to the 
oil and water mixture. The resulting gel emulsion was mixed with ZOL 
solvent using a mixer with 40 µg ZOL for every 25 mg gel.
Physical and drug content stability studies
All the gel emulsions of ZOL prepared with VCO were packed in 
Eppendorf tubes and checked for stability for 28 days at 25°C and 
40°C. Gel emulsion samples were evaluated after the formulation 
was prepared (baseline), at days 7, 14, and 28, for pH value, viscosity, 
spreadability, adhesive strength, and drug content.
Evaluation of ZOL gel emulsion preparations
Organoleptic evaluation
The prepared ZOL gel emulsion was visually assessed for appearance, 
color, consistency, taste, and odor every week until 4 weeks when 
stored at 25°C and 40°C.
pH determination test
1 g ZOL gel emulsion was dispersed in 100 ml distilled water. The pH 
of the gel emulsion was determined using a digital pH meter (Eutech 
Instruments, USA) by completely plunging the electrode’s glass into the 
gel emulsion.
Viscosity test
The viscosity of the ZOL gel emulsion was measured using a viscometer 
(Brookfield, USA) with spindle no. 6 and spindle speed 20 rpm. The 
corresponding dial reading was recorded at each speed.
Spreadability test
Spreadability was determined by placing the gel emulsion between two 
glass plates and then placing a 100-g stone on top of the plates for 1 min. 
Then, the farther diameter of the spread gel emulsion was measured.
Adhesive strength test
Adhesive strength was evaluated by putting the gel between two glass 
plates and placing a 250-g stone on top of the glass plates for 5 min. 
Then, an 80-g glass plate was glued to one of the two plates touching the 
gel, and the time required for the glass plates to detach was recorded.
Determination of drug content
Drug content of the gel emulsion was determined by dissolving 
100 mg gel emulsion in 5 ml distilled water. Next, 1 ml of this solution 
was diluted with distilled water to make the volume of 5 ml. Then, 
the gel emulsion was subjected to analysis using spectrophotometer 
(Spectroquant Pharo 300, Germany). The amount of drug content was 
calculated from the calibration data; the absorbance was measured at 
210 nm.
Statistical analysis
Intra- and inter-observer reliabilities were analyzed using independent 
t-test. Data were analyzed using SPSS 23.0 version with independent 
t-test to assess the differences in stability of ZOL gel emulsion at 25°C 
and 40°C and with repeated measures analysis of variance (ANOVA) to 
calculate the differences in stability of ZOL gel emulsion at days 1, 7, 
14, and 28 and post hoc Bonferroni test to see multiple comparisons 
and which parameters were different. The result was considered 
statistically significant when p<0.05.
RESULTS
The result of the intra- and inter-observer reliability test with 
independent t-test showed that there was no significant difference 
for viscosity and spreadability value of ZOL gel emulsion between 
researches (p<0.05). All the stability machines had already calibrated 
before use. After preparation of the ZOL gel emulsion, it was evaluated 
for physical appearance and stability. When stored for 28 days at 25°C, 
the formulation had a white viscous, creamy, smooth homogenous 
texture, a characteristic odor and taste of coconut extract, and no 
trapped bubbles. However, when stored at 40°C for the same duration, 
its consistency was found to be hard. Indeed, all the stability tests for 
the ZOL gel emulsion stored at 40°C over the 28-day study period could 
not be performed due to the poor consistency of the gel emulsion. The 
results are summarized in Table 1.
The pH of ZOL gel emulsion at baseline was reasonably constant at 
about 5.79, and it slightly decreased throughout the 28-day storage 
period. Table 2 showed the result of post hoc Bonferroni test of repeated 
measure ANOVA. The differences in mean pH value for ZOL gel emulsion 
stored at 25°C and 40°C are significantly different (p<0.05) (Fig. 1). The 
specific value of the differences for all parameters is shown in Table 2. 
Fig. 2 demonstrates the result of the viscosity of ZOL gel emulsion over 
28 days. The viscosity ranged from 77,000 to 86,000 cps. The viscosity 
of the gel emulsion increased on days 7 and 14 at both temperatures and 
decreased on day 14 at 25°C storage, then raised up on day 28 (Fig. 2).
The spreadability of the emulsion at both storage temperatures 
decreased significantly over the 28-day test period (p<0.05). These 
results have a nonlinear relationship to the viscosity values of the 
ZOL gel emulsion (Fig. 3). The values of adhesive strength of ZOL gel 
emulsion are summarized in Figs. 4 and 5. The increment value of 
adhesive strength at 25°C and 40°C during the 28 days has a linear 
relationship to the spreadability of the ZOL gel emulsion.
The drug content of the ZOL gel emulsion ranged from 57.62 
to 55.32 ppm. The drug content value of ZOL gel emulsion was 
Table 1: Organoleptic evaluation of ZOL gel emulsion
Test Evaluation
Baseline Day 7 Day 14 Day 28





Solid white Solid white Solid white Solid white Solid white Solid white Solid white Solid white
Coconut Coconut Coconut Coconut Coconut Coconut Coconut Coconut
Coconut Coconut Coconut Coconut Coconut Coconut Coconut Coconut
Viscous Viscous Viscous Viscous Viscous Viscous Viscous Solid hard
Homogeneity Excellent Excellent Excellent Excellent Excellent Excellent Excellent Excellent
ZOL: Zoledronate
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Table 2: Parameters values of stability and drug content ZOL gel emulsion testing between 0, 7, 14, and 28 days in 25°C and 40°C
Time (days) pH Viscosity Spreadability Adhesive strength Drug content
25°C 40°C 25°C 40°C 25°C 40°C 25°C 40°C 25°C 40°C
0–7 0.021* 0.055 0.478 0.105 1.000 1.000 0.550 1.000 0.000* 0.000*
0–14 0.029* 0.001* 0.468 0.018* 1.000 0.545 0.003* 0.001* 0.000* 0.000*
0–28 0.000* - 0.031* - 1.000 - 0.001* - 0.000* -
7–14 1.000 0.000* 1.000 0.718 1.000 0.757 0.012* 0.004* 0.000* 0.000*
7–28 0.004* - 0.212 - 1.000 - 0.003* - 0.000* -
14–28 0.05 - 1.000 - 1.000 - 1.000 - 0.000* -
Post hoc Bonferroni test. *p<0.05, ZOL: Zoledronate
Fig. 1: Mean value of pH of zoledronate (ZOL) gel emulsion at 25°C and 40°C. The pH value of both gel emulsions decreased significantly 
after 7 and 14 days compared to the 1st day of testing (p<0.05). pH tests for the ZOL gel emulsion stored at 40°C over the 28-day study 
period could not be performed due to the poor consistency of the gel emulsion
Fig. 2: Mean value of viscosity of zoledronate (ZOL) gel emulsion at 25°C and 40°C during the 28-d study period. Viscosity tests for the ZOL 
gel emulsion stored at 40°C over the 28-day study period could not be performed due to the poor consistency of the gel emulsion
Fig. 3: Mean value of the spreadability of zoledronate (ZOL) gel emulsion at 25°C and 40°C. Spreadability tests for the ZOL gel emulsion 
stored at 40°C over the 28-day study period could not be performed due to the poor consistency of the gel emulsion
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significantly different from the value of the 1st day of testing (p<0.05). 
Fig. 6 illustrates this degradation of drug content over the study 
period.
DISCUSSION
ZOL gel emulsions or emulgels are compounds that when mixed with 
VCO can become semi-solid after mixing with the gelling agent CMC. As 
a topical medication, gel emulsions have numerous advantages, such as 
the ability to deliver hydrophobic drugs that cannot be used in the form 
of a gel. Gel emulsions are also easily rubbed on the skin or mucous 
membranes due to their excellent ability to penetrate the skin [16-18]. 
VCO was selected as the oil base in this formulation because it has 
natural beneficial effects on health [19]. VCO is also characteristically 
smooth due to its fatty acid component, which serves as a penetration 
enhancer. Some studies have shown that VCO also has polyphenol 
and α-tocopherols components that produce antioxidant effects and 
reduces cholesterols [13,14]. In our study, a preservative agent was 
added to the ZOL gel emulsion to prevent microbial growth and to 
maintain the oxygen in the oil base [20].
The 25°C temperature that chosen in this study represented the room 
temperature for drug storage and the 40°C reflected the accelerated 
testing for stability drugs in 28 days so the temperature must be 
raised [15]. The physical appearance of ZOL gel emulsion during the 
storage at 25°C showed that the formulation was stable and homogenous 
till day 28. The consistency and color of the gel emulsion were smooth 
and did not exhibit phase separation before or after the addition of the 
gelling agent, showing that the gel emulsion was stable [21]. Its color, 
taste, and odor were also acceptable. However, the consistency of the 
gel emulsion became solid at the 40°C storage by day 28; thus, all the 
evaluation tests could not be performed for samples stored at 40°C.
In this study, the pH of the gel emulsion steadily decreased each week, 
dropping from 5.79 to 5.67. Some studies have reported that the 
fluctuation of pH value could be an indication of microbial growth, 
changes in temperature, poor storage condition, chemical reactions, or 
decomposition of the constituent ingredients [22]. Lee et al. reported 
that there is a relationship among the values of moisture content, pH, 
and viscosity [23]. Decreasing moisture in the gel emulsion was similar 
to the effect of a decrease in its pH value [23]. In our study, the storage 
temperature was the leading cause for the reduction in the pH of the gel 
emulsion stored at 40°C. The pH value of the gel emulsion after storing 
for 28 days at both temperatures was almost constant and stable. The 
pH value is similar to that of the oral cavity, which is approximately 6–7, 
which helps prevent irritation of the oral mucous [24].
The increment of the viscosity had a linear relationship with 
temperature [24,25]. Perhaps this anomalous viscosity-temperature 
behavior for gel emulsion could be caused by combinations of CMC, 
packaging, and temperature [26]. In-gel emulsions, CMC is the gelling 
agent. During storage, CMC as a gelling agent could be compromised 
and lead to a change in the resulting product. This phenomenon could 
be induced by temperature and packaging that is not airtight [24]. 
These factors could result in moisture absorption and increased water 
volume in the gel emulsion. Owen et al. reported that an increase in 
storage temperature also increases the apparent viscosity [25]. In 
addition, Iradhati and Juhfri noted that globule flocculation could 
increase the viscosity during the preparation of ZOL gel emulsion [21]. 
The fluctuation in the viscosity values on day 14 at 40°C storage and day 
14 at 25°C storage might be caused by syneresis, the discharge of the 
entangled fluid in the gel emulsion to the surface [27].
The spreadability test was performed to determine the ability of the gel 
emulsion to spread on the skin and rapidly deliver its effectiveness [28]. 
The spreadability was reduce in the range of 2.2–2 cm, confirming that it 
can spread uniformly and smoothly. This gel emulsion formulation also 
showed an inverse relationship between spreadability and viscosity. 
The gel emulsion with the highest viscosity also had the minimum 
spreadability on the skin or oral mucous and vice versa [27,28]. Some 
studies have concluded that the best spreadability value for oral mucous 
is in the range of 3–5 cm [28].
The adhesive strength value of ZOL gel emulsion ranged from 2.5 to 2.9 s. 
The purpose of this test is to determine the duration of attachment of 
the gel to the skin [28]. This duration was found to be proportional 
to the viscosity of ZOL gel emulsion [27]. The values of spreadability 
and adhesive strength of the ZOL gel emulsion were below the average 
values for oral mucous, which contains saliva that can remove the gel 
emulsion quickly; hence, if the spreadability value is small and the 
Fig. 4: Mean value of adhesive strength of zoledronate (ZOL) gel emulsion at 25°C and 40°C. Adhesive strength tests for the ZOL gel 
emulsion stored at 40°C over the 28-day study period could not be performed due to the poor consistency of the gel emulsion
Fig. 5: Graph of the standard calibration curve of zoledronate 
bisphosphonates
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duration of adhesive strength of ZOL gel emulsion is short, it will be 
favorable for effective drug delivery.
We found that degradation of the drug content in the ZOL gel emulsion 
was occurring, but not enough to jeopardize effective delivery of a 
therapeutic dose. The half-life of ZOL BP in bone is very long, ranging 
from 1 to 10 years and the degradation of this drug is still in the range 
of the half-life of ZOL [29,30].
Orthodontic tooth movement is characterized by the remodeling of 
periodontal and dental tissues by subjecting them to the mechanical 
force. The tooth movement produced by bone resorption on the 
compression side of the tooth that is induced by osteoclast and bone 
formation on the tension side that is induced by osteoblast [8,31]. Tooth 
movement in orthodontic treatment is not only aimed at shifting teeth 
appropriately but also simultaneously anchoring the tooth in its new 
position. However, undesired movement of the anchored teeth and 
relapse of moved teeth after orthodontic treatment are major clinical 
challenges for an orthodontist, both during and after orthodontic 
treatment [8]. According to Parlina et al., ZOL gel emulsion has the 
potential of inhibiting osteoclast activity and reducing bone resorption; 
thus, it may be effective in reducing the loss of anchorage and preventing 
relapse in orthodontic treatment [13]. From our study, it appears that 
the physical stability and drug content of the ZOL gel emulsion are 
sufficiently stable for its use by orthodontists.
CONCLUSION
This study found that the ZOL gel emulsion was stable when stored 
at 25°C. The organoleptic, pH, viscosity, spreadability, and adhesive 
strength values were also stable, and the degradation was constant. 
It is recommended that the storage of ZOL gel emulsion be at room 
temperature and in airtight containers. This study represented that ZOL 
gel emulsion was stable for clinical use, but the further in vitro study 
must be carried out.
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